Cingulate Inc. (NASDAQ:CINGW) Short Interest Update

Cingulate Inc. (NASDAQ:CINGW) was the target of a large increase in short interest in May. As of May 29th, there was short interest totaling 10,882 shares, an increase of 186.7% from the May 14th total of 3,796 shares. Based on an average daily volume of 57,882 shares, the days-to-cover ratio is presently 0.2 days.

Cingulate Stock Up 50.0%

CINGW stock traded up $0.01 during mid-day trading on Friday, hitting $0.03. The company had a trading volume of 100 shares, compared to its average volume of 41,306. Cingulate has a 12-month low of $0.02 and a 12-month high of $0.18. The company has a 50-day moving average price of $0.02 and a 200 day moving average price of $0.05.

Cingulate Company Profile

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.